Aktienanalyse zu National Research Corp (NRC)NRCNational Research Corp

NRC Health, formerly National Research Corporation, provides healthcare experience improvement solutions. The Company is focused on improving the challenged healthcare ecosystem with stakeholder experience insights, market intelligence data, and software tools that enable health systems to improve patient outcomes and hospital operations. Its solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. The Company's portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. It operates in the Industrials sector (SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry).

National Research Corp (NRC) is a good buy right now due to its strong recent performance, with a current price of $21.93 and a year-to-date change of +21.63%. The company has shown resilience with a gross margin of 56.41% and a forward P/E ratio of 17.21, indicating potential for future earnings growth. However, the main risk is its high debt-to-equity ratio of 1374.68%, which could impact financial stability if not managed properly.